Stay Connected with ERT:
- Regulatory Trends in Reviewing Risk/Benefit Assessments: U.S. FDA Perspective
- Drug-induced Hypertension – Potential New FDA Guidance?
- Why Use Ambulatory Blood Pressure Monitoring (ABPM) in Clinical Research?
- Improving Your Drug’s Value Proposition throughout the Product Lifecycle: How Optimized Clinical Outcomes Assessment (COA) Strategies Can Drive Commercialization Success
- Metrics Champion Consortium – Cardiopulmonary Performance Metrics Initiative
Monthly Archives: January 2011
Discover More: Prospective Assessment of Suicidal Ideation and Behavior in Clinical Studies We will begin our journey together by discussing the prospective assessment of suicidal ideation and behavior in clinical studies. This article is based on an interview with Dr. … Continue reading
Cardiac Safety, Respiratory Solutions and Multi-Mode ePRO – Get Your Clinical Trial Done Right with ERT
Welcome to the new ERT blog! It is great to see you here. This blog is dedicated to providing the latest news and information on cardiac safety, respiratory solutions and multi-mode ePRO solutions to biopharmaceutical, contract research organizations, medical device companies … Continue reading